Vasculitis. Marwan Adwan. 4 th year MBBS. Consultant Rheumatologist. MBChB, MRCPI, MSc, MRCP (rheum)

Similar documents
PAEDIATRIC VASCULITIS

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Vasculitis local: systemic

Atlas of the Vasculitic Syndromes

VASCULITIS. Case Presentation. Case Presentation

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth

Vasculitis local: systemic

The Vasculitis Syndromes

Overview. = inflammation of vessel wall. Symptoms and signs depend on the tissue of which the vessels are affected

VASCULITIC SYNDROMES. Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis

Done by: Shatha Khtoum

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

CUTANEOUS VASCULITIS. Katharine Warburton ST6 Dermatology

Small Vessel Vasculitis

A. Smržová. III. Interní klinika FN Olomouc nefrologická, revmatologická a endokrinologická

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Small Vessel Vasculitis

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Diagnostic Procedures for Vasculitis

FAQ Identifying and enrolling participants

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service

A CRP B FBC C LFT D blood culture E uric acid

RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS

Vasculitides in Surgical Neuropathology Practice

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital

TAKAYASU S ARTERITIS. Second-stage symptoms include:

Rituximab treatment for ANCA-associated vasculitis in childhood

EDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie

GRANULOMATOSIS WITH POLYANGIITIS

CHECK LIST FORM-SCREENING

A number of factors point to the likelihood of a person with RA developing RV:

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura)

AKI Case study -Vasculitis. Sarah Mackie Renal Practice Development Nurse King s College Hospital - London

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

Scleritis LEN V KOH OD

Vasculitis. Seth Mark Berney, MD Professor of Medicine Chief, Division of Rheumatology University of Arkansas for Medical Sciences

VASCULITIS AND VASCULOPATHY

Rheumatology Primer: What Labs and When

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

29 Glomerular disease: an overview

CHECK LIST FORM-SCREENING

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

ARTHRITIS FOUNDATION VASCULITIS

Autoimmunity. Autoimmune Disease

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018

Vasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP

ANCA-associated systemic vasculitis (AASV)

Year 2004 Paper one: Questions supplied by Megan

Dr Kusala S. Gunasekara MBBS(Col),MD(Med),MRCP(UK) Acting Consultant Rheumatologist DGH-Matale

Differential Diagnosis of Neuropathies and Compression. Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre

CENTRAL NERVOUS SYSTEM VASCULITIS

vasculitis Patomorfologia vasculitis (arteritis) caused by infections vasculitis (arteritis) caused by infections

Managing Acute Medical Problems, Birmingham Vasculitis. David Jayne. University of Cambridge

Patient with Daily Headache NTERNATIONAL CLASSIFICATION HEADACHE DISORDERS. R. Allan Purdy, MD, FRCPC,FACP. Professor of Medicine (Neurology)

Vasculitis and the Dermatologist: General approach, pitfalls, and pearls

Glomerular pathology in systemic disease

Review Article. Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis. Milind Aurangabadkar

Index. Note: Page numbers of article titles are in boldface type.

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature

Crescentic Glomerulonephritis (RPGN)

The role of pathology in the diagnosis of systemic vasculitis

APPROACH TO PATIENTS WITH POLYARTHRALGIA

DIABETES MELLITUS. Kidney in systemic diseases. Slower the progression: Pathology: Patients with diabetes mellitus are prone to other renal diseases:

Guideline on the clinical management of Henoch Schonlein Purpura (HSP)

Takayasu s arteritis. Justin Mason. Professor of Vascular Rheumatology Imperial College London Hammersmith Hospital

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

Shawkat Michel, M.D.

TREATMENT OF ANCA-ASSOCIATED VASCULITIS

ANCA associated vasculitis in China

CHECK LIST FORM-MONTH 27 (Please note Month 27 is from enrolment not randomisation)

KAWASAKI DISEASE. What is Kawasaki disease? Causes

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease

Professor Helen Danesh-Meyer. Eye Institute Auckland

Plan. Sarcoidosis 21/07/2017. Sarcoidosis Liver involvement. Sarcoidosis GI involvement. Sarcoidosis Diagnosis

Update on nomenclature and classification of vasculitis

VASCULITIS ACOI Robert L. DiGiovanni, DO, FACOI

Cerebrovascular Disease

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Everyday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant

Case Presentation. Rafid Asfar, MD

anti-neutrophil cytoplasmic antibody, myeloperoxidase, microscopic polyangiitis, cyclophosphamide, corticosteroid

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

Update in Vasculitis. Anatomy of vasculitis. General Principles of Vasculitis. Not necessarily as rare as one might think

Concise guidance: diagnosis and management of giant cell arteritis

Clinical characteristics and outcome of vasculitides

Henoch Schonlein Purpura

Update and Review on Vasculitis. Ramona Raya, MD ACP Internal Medicine Congress August 7, 2015

HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT

17 : 3. Renu Saigal, Amit Kansal, Jaipur ABSTRACT:

a mimicker of Wegener s Granulomatosis

Transcription:

Vasculitis 4 th year MBBS Marwan Adwan MBChB, MRCPI, MSc, MRCP (rheum) Consultant Rheumatologist

Case 1 A 45 man presents with 3 wk hx of fever, fatigue, malaise, abdo pain and polyarthralgia. He noticed a rash on both legs & pain & weakness of L foot. O/E: temp 39, abdo tender diffusely. Livedo reticularis & palpable purpura on legs, L foot drop

Investigations Hb, platelets, ESR 95 ANA, ANCA, hep B&C negative Abdo x ray normal Skin biopsy: non granulomatous necrotising vasculitis NCS: L common peroneal nerve lesion Abdo angio: microaneryms & stenoses in mesenteric arteries.

Diagnosis??

Objectives Definition & Classification Epidemiology Manifestations & differential diagnosis Large vessel vasculitis ANCA asscociated vasculitis Medium vessel vasculitis Small vessel vasculitis Other

Vasculitis A heterogeneous group of disorders linked by the primary finding of inflammation within blood vessel walls. At least 20 forms of systemic vasculitis are recognized Uncommon Cause significant morbidity and mortality

Classified by the size of blood vessel involved: Small vessel (capillaries and postcapillary venules) Medium vessel (muscular arteries and arterioles) Large vessel (the aorta and its major branches).

Vasculitis May be: primary or secondary

Drugs that may cause vasculitis: Prescribed Propylthiouracil Hydralazine Allopurinol Abused Cocaine Heroin Amphetamine

Epidemiology Diseases of childhood or old age GCA most common Scandinavia and relatively uncommon in Africans and Japanese Takayasu more common in Japan AAV overall incidence (20/millon/year) Cause unknown? Environmental agent (unknown) in a genetically predisposed host

Typical clinical manifestations of large-, mediumand small-vessel involvement by vasculitis Large Medium Small Headache Limb claudication Asymmetric blood pressures Absence of pulses Bruits Aortic dilatation Cutaneous nodules Ulcers abdominal pain Livedo reticularis Digital gangrene Mononeuritis multiple Microaneurysms Purpura Vesiculobullous lesions Urticaria Glomerulonephritis Alveolar hemorrhage Cutaneous extravascular necrotizing granulomas Splinter hemorrhages Scleritis/episcleritis/uveitis Constitutional symptoms: fever, weight loss, malaise, arthralgias/arthritis (common to vasculitides of all vessel sizes)

Clinical Features Suggesting Vasculitis Multisystem inflammatory disease Rapidly progressive major organ dysfunction Constitutional symptoms (fever, weight loss) Unexplained infarction in multiple vascular territories High ESR, severe anemia, thrombocytosis Evidence of small-vessel inflammation: In the kidneys = active urinary sediment (RPGN) In the lungs = hemoptysis, dyspnea(diffuse alveolar hemorrhage ) In the skin = palpable purpura/hemorrhage Acute neurologic changes Foot drop Altered mental status

Differential diagnosis of vasculitis Infection Bacterial endocarditis. Hepatitis B Hepatitis C HIV Occult abscess Syphilis Malignancy Lymphoma Hodgkins disease. Hypernephroma Metastatic carcinoma Multiple myeloma Macroglobulinemia Autoimmune disease Rheumatoid arthritis. Systemic lupus Multiple emboli/, cholesterol emboli. Drug allergy

Case 2 A 48 year old man, IVDU, presented with a 4 week history of generally feeling unwell and purpuric rash over both legs. He looked ill, and there were several nail fold infarcts and vasculitic lesions over his fingers. Blood picture was in keeping with systemic inflammatory response. CXR showed cavitating lesions. Skin biopsy showed leucocytoclastic vasculitis. His illness was attributed to systemic vasculitis and specialist opinion was sought.

Several days after admission serial blood cultures and echocardiogram were arranged. Blood cultures grew Staphylococcus aureus and TTE showed vegetations around the tricuspid valve consistent with right heart endocarditis. The cavitating lesions were lung abscesses secondary to septic emboli.

Because treatment of vasculitis entails the use of immunosuppressive drugs, the consequences of not recognising infection would be disastrous. Thus, it is mandatory to perform a full infection screen in all patients with suspected vasculitis

Large vessel vasculitis

Giant cell arteritis (GCA) Rare under age 50 Headache: temporal / occipital Scalp tenderness? Thickened, nodular, tender TA? / absent TA pulse Jaw claudication: internal maxillary artery Tingling tongue: lingual artery Amaurosis fugax Unilateral permanent loss of vision other eye affected within 1-2 wks (ophthalmic & posterior ciliary arteries)

GCA Diagnosis 1. Normocytic anaemia 2. High ESR & CRP 3. Temporal artery biopsy: skip lesions common Complication: sudden loss of vision if untreated Treatment: Steroids (good response)

GCA

Polymyalgia Rheumatica (PMR) Closely associated with GCA May be seen in 40 50% of patients With GCA Pain and stiffness in shoulder and pelvic girdles worse in morning Good response to steroids

Takayasu s Arteritis Affects young people <40 Characterized by stenosis, occlusion, and sometimes aneurysm formation of large arteries Commonest in Asia, the Middle East and South America F:M = 9:1 No autoantibodies

Takayasu s Arteritis Clinical Features 3 phases: 1. Systemic phase: Fatigue, weight loss, night sweats, fever, arthralgia, and myalgia 2. Vascular phase: asymmetry of peripheral pulses claudication of arm or legs transient visual disturbance, scotoma, blurring, or diplopia 3. Burnt-out pulseless phase

Takayasu s Arteritis: Examination Diminished or absent pulses Bruits Asymmetric blood pressure between extremities Carotidynia Hypertension

Takayasu s Arteritis: radaiology

18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) 18F-FDG is taken up by metabolically active cells including at sites of inflammation. Uptake can be visualized in the walls of inflamed large vessels

Takayasu s Arteritis: Treatment High-dose oral prednisolone at 0.5 1 mg/kg Steroid-sparing agents: Azathioprine, methotrexate Surgery

ANCA associated vasculitides

ANCA Associated Vasculitides (AAV) 1. Microscopic polyangiitis (MPA) 2. Granulomatosis with polyangiitis (GPA, formerly Wegener s) 3. Eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg- Strauss)

Antineutrophil Cytoplasmic Antibodies (ANCA) Antibodies against azurophilic granules in neutrophils 2 types: Cytoplasmic (canca): against proteinase 3. specific for Wegener s Perinuclear (panca): against myeloperoxidase. Occur in CSS & MPA panca in diseases other than primary vasculitis in directed against other antigens (elastase, lactoferrin, cathepsin G)

ANCA canca panca

Microscopic Polyangiitis Presents: (MPA) acutely with renal disease RPGN, or Pulmonary-renal syndrome Affect small vessels (arterioles, venules, capillaries) panca directed against MPO

Pulmonary haemorrhage in MPA

Granulomatosis with polyangiitis (GPA, formerly Wegener s) Granulomatous necrotising vasculitis affecting small to medium vessels Affects ENT, kidney & lung ANCA in >90% (mostly canca) 10/million/year Aetiology unknown

GPA features Systemic: Fever, weight loss, myalgia, and arthralgia Lung: haemoptysis, dysponea Skin: purpura ENT: epistaxis, nasal crusting, sinusitis. nasal collapse GI: vasculitis Neuro: neuropathy Renal: RGPN (Paucimmune, crescentic) Eye: scleritis, proptosis due to retro-orbital mass

Saddle-nose in WG

Normal GPA/Wegener s

Exophthalmos due to orbital pseudotumors Intractable pain and loss of vision Refractory to therapy

WG: Left orbital mass causing proptosis and visual loss through compression of the optic nerve

Multiple bilateral pulmonary nodules, many of which have cavitated.

Eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg- Strauss) Eosinophil-rich granulomatous inflammation involving the respiratory tract, & necrotizing vasculitis affecting small to medium-sized vessels, associated with asthma & eosinophilia Cardiac involvement common: The principal cause of morbidity and mortality and accounts for 50% of deaths panca eosinophil count is useful in monitoring dis activity

EGPA: 3 phases 1. Prodromal phase may last for years: asthma, atopic features (e.g., allergic rhinitis, nasal polyposis). 2. Eosinophilic phase Peripheral blood eosinophilia and eosinophilic tissue infiltration of lung and GI tract. 3. Vasculitic phase The most severe phase: may only become apparent several years after prodromal phase. Malaise, lethargy, weight loss, fevers & vasculitis

Treatment of ANCA associated vasculitis Induction: IV steroids + IV cyclophosphamide OR rituximab Maintenance : Oral steroids + Oral MTX or azathioprine

Medium Vessel Vasculitis

Polyarteritis nodosa (PAN) A multisystem, necrotizing vasculitis of small- and medium-sized muscular arteries Involvement of the renal and visceral arteries is characteristic. PAN does not involve lungs No ANCA association Hepatitis B in 10-30%

PAN

Digital tip infarction in polyarteritis nodosa

Livedo reticularis in polyarteritis nodosa

Angiogram showing microaneurysms in polyarteritis nodosa

Mononuritis multiplex

Small Vessel Vasculitis

Hypersensitivity Vasculitis Primary or secondary Immune complex Most common form of vasculitis. Histology- leukocytoclastic vasculitis. Almost invariably involves skin:-palpable purpura Visceral involvement is infrequent, mild Alveolar hemorrhage Intestinal ischemia or hemorrhage Glomerulonephritis. Secondary:- Autoimmune disease Drugs. Infection. Allergy Hematologic

Hypersensitivity vasculitis/ IgA vsculitis (HSP) Vasculitis with IgA-dominant immune deposits affecting small vessels Age at onset <20 years (majority <10) The most common vasculitis in children Follows upper respiratory infection involves alternate complement pathway & therefore C3 & C4 are normal

HSP: Clinical features Purpuric rash on legs & buttocks Colicky abdo pain Melaena Arthralgia: transient and self-limiting Haematuria & proteinuria Sometimes focal or diffuse proliferative glomerulonephritis develops Sometimes intussusseption develops

HSP Diagnosis: Skin biopsy: leucocytoclastic vasculitis Immunoflorescence: IgA deposits Treatment: none Most have a self-limiting disease & settle within 2 3 weeks <5% of children develop chronic renal failure Renal failure is more common in adults

Henoch-Schӧnlein purpura (HSP)

Cryoglobulinaemia Cryoglobulins: immunoglobulins that precipitate at temperatures <37 C and redissolve on rewarming Associated with Hepatitis C virus infection Affects skin, kidneys & nerves Immune complex mediated Investigations: Cryoglobulins High RF Low C4 Hep C serology

Cryoglobulinaemia: Clinical features Purpura Joint pain Raynaud s Neuropathy Renal: membranoproliferative GN

Cryoglobulinaemia: Treatment Interferon alpha + ribavirin + rituximab Plasma exchange for severe cases to remove cryoglobulins

Other

Behcet s disease Common along the silk route HLA-B51 association Recurrent oral ulceration plus two of the following: Recurrent genital ulceration Eye lesions Skin lesions Pathergy test Oral ulcers heal without scarring Genital ulcers leave scars No confirmatory blood or histological test, diagnosis clinical

Behcet Oral ulcers

Genital ulcers Behcet skin lesions Acneiform lesions Erythema nodosumlike Superficial thrombophlebitis

Pathergy

Behcet Eye lesions Anterior uveitis & hypopyon

Vascular manifestations of Behcet s Arterial Aortic aneyrysm Carotid anerysm Pulmonary anerysm Venous superficial venous thrombosis DVT Vena cava thrombosis Cerebral venous thrombosis Budd-Chiari syndrome Portal vein thrombosis

Carotid aneurysm

Pulmonary artery aneurysm

Behcet: Nervous system invovement 1. Brainstem or corticospinal tract syndromes (neuro- Behçet's syndrome) 2. Venous sinus thrombosis 3. Aseptic meningitis 4. Isolated behavioral symptoms, or isolated headache 5. Cranial and Peripheral neuropathy 6. Optic neuritis 7. Vestibular involvement Poor prognosis is associated with a progressive course, parenchymal or brainstem involvement, and cerebrospinal fluid abnormalities

Behcet s Treatment Depends on manifestations Oral lesions: Colchicine Azathioprine Thalidomide Arthritis: Colchicine Eye: Steroids Azathioprine Interferon alpha MMF Infliximab Rituximab Vasculopathy: Steroids & cyclophosphamide Neurological: Steroids Interferon alpha Anti-TNF

Last Case A 52-year-old woman has had arthralgias and occasional purple spots on her legs for several years. She now presents with florid small, nonblanchable, palpable lesions on her legs and black fingers and obvious synovitis of multiple small joints. Some of the skin lesions have centers of necrosis. Radiographs of the hands and wrists show no erosions. In the past, she has been diagnosed at different times with RA and SLE, because of markedly positive RF, ANA, low C4, but normal C3 and Raynaud s. 30 years ago, she had a complicated but safe delivery of her only pregnancy, a breech presentation, which necessitated the transfusion of multiple units of blood.

What further investigations What s the diagnosis?

He who studies medicine without books sails an uncharted sea, but he who studies medicine without patients does NOT go to sea at all

Questions?

Vasculitis pearls 1. GCA is the most common vasculitis 2. Secondary vasculitis is more common than primary vasulitis 3. In GPA, the lung infiltrates are fixed, in EGPA, they are not fixed 4. renal and lung involvement is a negative prognostic factors in GPA or MPA 5. in EGPA most deaths occur from cardiac involvement.

6. Medium to small vessel respond to steroids + immunosuppressives 7. Large vessel respond to high dose steroids 8. Small vessel respond to low dose steroids 9. The appearance of active urinary sedement or rise in serum Cr in vasculitis is an indication for prompt aggressive treatment 10.Urinalysis is the most important investigation as prognosis is determined by the extent of renal involvement